1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
| Product Code | MDA MB 175 VII; MDA-MB-175VII; MDAMB175VII; MDA-MB-175; MDAMB175; MDA-175; MDA175; MD Anderson-Metastatic Breast-175-VII |
| Species | Human |
| Cat.No | ABC-TC0650 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Epithelial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃ |
| Source Organ | Breast |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Breast Cancer Cell Lines |
MDA-MB-175-VII is a human breast invasive ductal carcinoma (IDC) cell line that was originally isolated from the pleural effusion of a 56-year-old Black or African American female patient with invasive breast carcinoma. MDA-MB-175-VII exhibits epithelial-like morphology and semi-adherent culture properties. The stemline karyotype model number of MDA-MB-175-VII is 84 with a range from 82 to 89. This cell line is aneuploid; it is displaying chromosomal counts within the hypertetraploid to near-tetraploid range (PMID: 18516279). MDA-MB-175-VII is tumorigenic and metastasis. After 10^7 cells were inoculated subcutaneously in nude mice, all samples developed tumors within 21 days.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
MDA-MB-175-VII cell line serves as a valuable asset in cancer research. It aids in identifying high-risk factors associated with breast cancer. Additionally, it facilitates the identification of pivotal genes and expressed proteins that drive breast cancer cell proliferation, while also enabling preclinical assessments of specific antibody effectiveness. The cell line’s utility extends to evaluating the apoptotic and cytotoxic impacts of different drugs, enhancing our understanding of potential treatments.
